{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:34:18Z","timestamp":1787312058041,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.577751","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T03:07:25Z","timestamp":1602126445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Serological Protection 5\u20136 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes"],"prefix":"10.3389","volume":"11","author":[{"given":"Olubukola T.","family":"Idoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagritos D.","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba O.","family":"Sow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Geldmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Saathoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"B1","unstructured":"Background Paper on Yellow Fever Vaccine2013"},{"key":"B2","unstructured":"Recommended Routine Immunizations for Children2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2016.05.005","article-title":"Towards predicting protective vaccine responses in the very young","volume":"37","author":"Kollmann","year":"2016","journal-title":"Trends Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.vaccine.2014.05.040","article-title":"Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013\u2013recommendations","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1016\/j.vaccine.2017.06.087","article-title":"WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013","volume":"35","year":"2017","journal-title":"Vaccine."},{"key":"B6","first-page":"269","article-title":"Vaccines and vaccination against yellow fever","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"B7","first-page":"193","article-title":"Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017-2026","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jtm\/tay130","article-title":"Ten yearly yellow fever booster vaccinations may still be justified","volume":"25","author":"Plotkin","year":"2018","journal-title":"J Travel Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4269\/ajtmh.2011.10-0496","article-title":"Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil","volume":"85","author":"de Melo","year":"2011","journal-title":"Am J Trop Med Hyg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/M18-1529","article-title":"Long-term protection after fractional-dose yellow fever vaccination: follow-up study of a randomized, controlled, noninferiority trial","volume":"169","author":"Roukens","year":"2018","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jtm\/tay108","article-title":"Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers","volume":"25","author":"Lindsey","year":"2018","journal-title":"J Travel Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2018.12.001","article-title":"Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa","volume":"162","author":"Jia","year":"2019","journal-title":"Antiviral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/14760584.2019.1640118","article-title":"Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children","volume":"18","author":"Idoko","year":"2019","journal-title":"Exp Rev Vaccines."},{"key":"B14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1590\/0074-02760150176","article-title":"A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213\/77 in children nine-23 months old","volume":"110","year":"2015","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella","volume":"29","author":"Nascimento Silva","year":"2011","journal-title":"Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S586","DOI":"10.1093\/cid\/civ603","article-title":"Immunogenicity of yellow fever vaccine coadministered with menafrivac in healthy infants in Ghana and Mali","volume":"61","author":"Roy Chowdhury","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2139\/ssrn.3346514","article-title":"Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study","volume":"19","author":"Domingo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0149871","DOI":"10.1371\/journal.pone.0149871","article-title":"A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination","volume":"11","author":"Wieten","year":"2016","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1016\/j.vaccine.2018.05.041","article-title":"Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study","volume":"36","author":"de Menezes Martins","year":"2018","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1471-2334-14-391","article-title":"Subdoses of 17DD yellow fever vaccine elicit equivalent virological\/immunological kinetics timeline","volume":"14","author":"Campi-Azevedo","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B23","volume-title":"Stata Statistical Software: Release 14","year":"2015"},{"key":"B24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health."},{"key":"B25","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot","year":"1962","journal-title":"Bull World Health Organ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.vaccine.2014.07.021","article-title":"Duration of post-vaccination immunity against yellow fever in adults","volume":"32","year":"2014","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.4269\/ajtmh.2012.12-0182","article-title":"Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination","volume":"87","author":"Gibney","year":"2012","journal-title":"Am J Trop Med Hyg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S493","DOI":"10.1093\/cid\/civ497","article-title":"Active Surveillance for adverse events after a mass vaccination campaign with a group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali","volume":"61","author":"Vannice","year":"2015","journal-title":"Clin Infect Dis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.577751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T03:07:37Z","timestamp":1602126457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.577751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2020.577751"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.577751","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"article-number":"577751"}}